
Medscape
<img alt="" height="1" width="1" />
FDA Clears Anticlotting Drug by Bristol and Pfizer
New York Times
The Food and Drug Administration on Friday approved Eliquis, an anticlotting drug that has been highly anticipated by cardiologists and is expected to be a blockbuster for Bristol-Myers Squibb, which will make the drug, and Pfizer, which will help market it.
FDA clears anti-clotting drug EliquisUSA TODAY
Pfizer, BMS win blockbuster FDA approval for EliquisFierceBiotech
FDA Approves Apixaban to Prevent Stroke in Nonvalvular AFMedscape
Wall Street Journal -Motley Fool
all 302 news articles »
More...